| Issue Date | Title | Author(s) | Source | WOS | Fulltext/Archive link |
| 2012 | Comparison of Genomic Signatures of Non-small Cell Lung Cancer Recurrence between Two Microarray Platforms | Chang, J. W. C.; Wei, N. C.; Su, H. J.; Huang, J. L.; Chen, T. C.; Wu, Y. C.; Yu, C. T.; Hou, M. M.; Hsieh, C. H.; Hsieh, J. J.; Wu, C. E.; Cheng, H. Y.; Todd Hsu ; Wang, T. H. | Anticancer Research | | |
| 2015 | Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resection | Wu, C. E.; Wang, C. W.; Huang, W. K.; Yang, C. T.; Wu, Y. C.; Hou, M. M.; Hsieh, C. H.; Hsieh, J. J.; Cheng, H. Y.; Todd Hsu ; Chang, J. W. C. | Japanese Journal of Clinical Oncology | | |
| 2012 | Erlotinib Treatment in Patients with Advanced Lung Adenocarcinoma with CISH-positive and CISH-negative EGFR Gene Alterations | Hou, M. M.; Huang, S. F.; Kuo, H. P.; Yang, C. T.; Tsai, Y. H.; Yu, C. T.; Lin, H. C.; Chen, C. H.; Wang, C. L.; Chung, F. T.; Hsieh, J. J.; Todd Hsu ; Cheng, H. Y.; Ou, L. Y.; Wang, H. M.; Lin, Y. C.; Chang, N. J.; Chang, J. W. C. | Anticancer Research | | |
| 2010 | Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma | Hou, M. M.; Hsieh, J. J.; Chang, N. J.; Huang, H. Y.; Wang, H. M.; Chuang, C. K.; Todd Hsu ; Chang, J. W. C. | Clinical Drug Investigation | | |
